Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis
Clinical trial NCT03904225 · UNKNOWN
Trial details
- NCT number
- NCT03904225
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2022-12-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.